Qasim A - Search Results

1

McCormick A, Qasim A. McCormick A, et al. Among authors: qasim a. Med J Malaysia. 2005 Jul;60 Suppl B:6-11. Med J Malaysia. 2005. PMID: 16108165 Review. No abstract available.

2

MELD score as a prognostic model for listing acute liver failure patients for liver transplantation.

Zaman MB, Hoti E, Qasim A, Maguire D, McCormick PA, Hegarty JE, Geoghegan JG, Traynor O. Zaman MB, et al. Among authors: qasim a. Transplant Proc. 2006 Sep;38(7):2097-8. doi: 10.1016/j.transproceed.2006.06.004. Transplant Proc. 2006. PMID: 16980011

3

Hepatic transplantation outcomes for carefully selected cirrhotic patients with hepatocellular carcinoma: experience at a small- to medium-volume centre.

Qasim A, Zaman MB, Maguire D, Geoghegan J, Gibney R, Nolan N, Traynor O, Hegarty J, McCormick PA. Qasim A, et al. Ir J Med Sci. 2009 Dec;178(4):469-72. doi: 10.1007/s11845-009-0333-5. Ir J Med Sci. 2009. PMID: 19360451

4

Endoscopic argon plasma coagulation for the treatment of gastric antral vascular ectasia (watermelon stomach): long-term results.

Sebastian S, McLoughlin R, Qasim A, O'Morain CA, Buckley MJ. Sebastian S, et al. Among authors: qasim a. Dig Liver Dis. 2004 Mar;36(3):212-7. doi: 10.1016/j.dld.2003.11.028. Dig Liver Dis. 2004. PMID: 15046192

5

Significant influence of the primary liver disease on the outcomes of hepatic retransplantation.

Qasim A, Zaman BM, Geoghegan J, Maguire D, Traynor O, Hegarty J, McCormick PA. Qasim A, et al. Ir J Med Sci. 2009 Mar;178(1):47-51. doi: 10.1007/s11845-008-0234-z. Epub 2008 Nov 4. Ir J Med Sci. 2009. PMID: 18982406

6

Improved survival outcomes for liver transplantation.

Qasim A, McCormick PA, Tajuddin T, Zaman MB, Traynor O, Hegarty J, Geoghegan J. Qasim A, et al. Ir Med J. 2007 Mar;100(3):389-90. Ir Med J. 2007. PMID: 17491536

7

Appropriateness of gastric antisecretory therapy in hospital practice.

Sebastian SS, Kernan N, Qasim A, O'Morain CA, Buckley M. Sebastian SS, et al. Among authors: qasim a. Ir J Med Sci. 2003 Jul-Sep;172(3):115-7. doi: 10.1007/BF02914494. Ir J Med Sci. 2003. PMID: 14700112

8

5-Aminosalicylates in inflammatory bowel disease: choosing the right dose.

Qasim A, Seery J, O'Morain CA. Qasim A, et al. Dig Liver Dis. 2001 Jun-Jul;33(5):393-8. doi: 10.1016/s1590-8658(01)80008-6. Dig Liver Dis. 2001. PMID: 11529648 Review. No abstract available.

9

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients.

Qasim A, Sebastian S, Thornton O, Dobson M, McLoughlin R, Buckley M, O'Connor H, O'Morain C. Qasim A, et al. Aliment Pharmacol Ther. 2005 Jan 1;21(1):91-6. doi: 10.1111/j.1365-2036.2004.02210.x. Aliment Pharmacol Ther. 2005. PMID: 15644050 Free article.

10

Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease.

Qasim A, McDonald S, Sebastian S, McLoughlin R, Buckley M, O'Connor H, O'Morain C. Qasim A, et al. Scand J Gastroenterol. 2007 Feb;42(2):194-9. doi: 10.1080/00365520600825166. Scand J Gastroenterol. 2007. PMID: 17327939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters